Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku
Fujitsu Japan Limited announced that it will initiate a new research project with a research team led by Takefumi Yamashita, Project Associate Professor of...
Cellenkos Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need
Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced that Cellenkos®, Inc., a privately held, clinical-stage biotechnology...
Bharat Biotech concludes final analysis for Covaxin efficacy from phase 3 clinical trials
Bharat Biotech, a global leader in vaccine development and innovation, announced safety and efficacy analysis data from Phase III clinical trials of COVAXIN®, a...
RedHill Biopharma’s Opaganib Inhibits COVID-19 Variants in Preclinical Study
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced preliminary results of a new preclinical study showing potent inhibition of COVID-19 variants of concern by...
Tech Mahindra partners StaTwig for blockchain-based traceability solution for vaccine supply chain
IT major Tech Mahindra said it has partnered with StaTwig, a Singapore and Hyderabad-based digital supply chain solution provider, to implement vaccine traceability platform...
CluePoints Launch Post-COVID Trial Assurance Solution
CluePoints, the premier provider of Risk-Based Quality Management Solutions for clinical trials, has launched a new Post-COVID Trial Assurance Solution as part of its mission...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...